Populational Uses of Complementary Therapies via a Digital Platform in France: Motivations and Needs.

IF 1.3 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Journal of Integrative and Complementary Medicine Pub Date : 2025-01-10 DOI:10.1089/jicm.2024.0519
Alain Toledano, Solange Arnaud, Marc Bollet, Hanah Lamallem, Olivier Bauduceau, Ilan Darmon, Hanene Boudabous, Nathaniel Scher
{"title":"Populational Uses of Complementary Therapies via a Digital Platform in France: Motivations and Needs.","authors":"Alain Toledano, Solange Arnaud, Marc Bollet, Hanah Lamallem, Olivier Bauduceau, Ilan Darmon, Hanene Boudabous, Nathaniel Scher","doi":"10.1089/jicm.2024.0519","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Complementary and integrative medicine (CIM) encompasses over 400 modalities, according to the World Health Organization (WHO). In 2011, 70% of the European Union's population reported having used CIM at least once, with 25% using it annually. This study examines the engagement, motivations, and satisfaction of users in the French health care system through data from Medoucine, France's largest online platform for complementary therapies. <b><i>Methods:</i></b> A cross-sectional descriptive analysis was conducted using Medoucine's database from 2017 to 2023, adhering to the Strengthening the Reporting of Observational Studies in Epidemiology guidelines. Data were sourced from practitioner profiles, appointment logs, and patient comments collected at baseline (day 0, J0) and follow-up (day 30, J30). Survey questions, including \"What type of complementary therapy are you seeking?\" provided clarity on how CIM therapies were introduced. The study included a \"recommendation question\" at baseline to evaluate satisfaction: \"Would you recommend this practitioner to your friends and family?\". Response rates varied between 10% and 67%, depending on the question. Categorical variables were analyzed as percentages. <b><i>Results:</i></b> Among 225,251 platform users, 67.7% (152,464) responded to the recommendation question at J0, 15% (33,823) reported health improvements at J30, and 10% (22,596) discovered sustainable health strategies. Most users were women (68.6%). Key motivations included well-being and personal development (17.4%), stress, anxiety, and phobias (17.1%), and sleep disorders (7%). Hypnosis (15%), traditional Chinese medicine (8.4%), and reflexology (6.7%) were the most commonly selected modalities. At J30, 74.8% reported health improvements, with notable benefits for well-being (80.7%) and stress (76.3%). <b><i>Conclusion:</i></b> This study underscores the growing demand for CIM therapies in France, driven by a need for stress relief, personal development, and physical and psychological health management. High satisfaction rates and perceived health benefits highlight the potential of CIM to complement conventional care. Integrating evidence-based CIM into mainstream health care systems, as recommended by the WHO, offers an opportunity to address patient needs and enhance health care delivery.</p>","PeriodicalId":29734,"journal":{"name":"Journal of Integrative and Complementary Medicine","volume":" ","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Integrative and Complementary Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/jicm.2024.0519","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Complementary and integrative medicine (CIM) encompasses over 400 modalities, according to the World Health Organization (WHO). In 2011, 70% of the European Union's population reported having used CIM at least once, with 25% using it annually. This study examines the engagement, motivations, and satisfaction of users in the French health care system through data from Medoucine, France's largest online platform for complementary therapies. Methods: A cross-sectional descriptive analysis was conducted using Medoucine's database from 2017 to 2023, adhering to the Strengthening the Reporting of Observational Studies in Epidemiology guidelines. Data were sourced from practitioner profiles, appointment logs, and patient comments collected at baseline (day 0, J0) and follow-up (day 30, J30). Survey questions, including "What type of complementary therapy are you seeking?" provided clarity on how CIM therapies were introduced. The study included a "recommendation question" at baseline to evaluate satisfaction: "Would you recommend this practitioner to your friends and family?". Response rates varied between 10% and 67%, depending on the question. Categorical variables were analyzed as percentages. Results: Among 225,251 platform users, 67.7% (152,464) responded to the recommendation question at J0, 15% (33,823) reported health improvements at J30, and 10% (22,596) discovered sustainable health strategies. Most users were women (68.6%). Key motivations included well-being and personal development (17.4%), stress, anxiety, and phobias (17.1%), and sleep disorders (7%). Hypnosis (15%), traditional Chinese medicine (8.4%), and reflexology (6.7%) were the most commonly selected modalities. At J30, 74.8% reported health improvements, with notable benefits for well-being (80.7%) and stress (76.3%). Conclusion: This study underscores the growing demand for CIM therapies in France, driven by a need for stress relief, personal development, and physical and psychological health management. High satisfaction rates and perceived health benefits highlight the potential of CIM to complement conventional care. Integrating evidence-based CIM into mainstream health care systems, as recommended by the WHO, offers an opportunity to address patient needs and enhance health care delivery.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过数字平台在法国补充疗法的人群使用:动机和需求。
背景:根据世界卫生组织(世卫组织)的数据,补充和综合医学(CIM)包括400多种模式。2011年,70%的欧盟人口报告至少使用过一次CIM, 25%的人每年使用一次。本研究通过法国最大的辅助疗法在线平台Medoucine的数据,考察了法国医疗保健系统中用户的参与度、动机和满意度。方法:根据《加强流行病学观察性研究报告指南》,采用Medoucine数据库2017 - 2023年进行横断面描述性分析。数据来源于基线(第0天,J0)和随访(第30天,J30)收集的医生简介、预约记录和患者评论。调查问题,包括“你在寻求哪种类型的补充疗法?”提供了如何引入CIM疗法的清晰信息。这项研究包括一个“推荐问题”作为评估满意度的基准:“你会把这个医生推荐给你的朋友和家人吗?”根据问题的不同,回复率在10%到67%之间。分类变量以百分比进行分析。结果:在225,251名平台用户中,67.7%(152,464)在J0时回答了建议问题,15%(33,823)在J30时报告了健康改善,10%(22,596)发现了可持续的健康策略。大多数用户是女性(68.6%)。主要动机包括幸福和个人发展(17.4%)、压力、焦虑和恐惧症(17.1%)以及睡眠障碍(7%)。催眠(15%)、中药(8.4%)和反射疗法(6.7%)是最常用的治疗方式。在30岁时,74.8%的人报告健康状况有所改善,对幸福感(80.7%)和压力(76.3%)有显著的好处。结论:这项研究强调了法国对CIM疗法的需求日益增长,这是由于对缓解压力、个人发展和身心健康管理的需求。高满意度和感知到的健康益处突出了CIM补充传统护理的潜力。按照世卫组织的建议,将基于证据的CIM纳入主流卫生保健系统,为解决患者需求和加强卫生保健服务提供了机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.30
自引率
0.00%
发文量
0
期刊最新文献
Biofield Therapies Clinical Research Landscape: A Scoping Review and Interactive Evidence Map. Research in Integrative and Complementary Medicine: Particularities, Challenges, Obstacles, and Misunderstandings. Part 2: Things Can also Work Differently when the Context is Different. Integration of Traditional, Complementary, and Integrative Medicine in the Institutionalization of Evidence-Informed Decision-Making: The World Health Organization Meeting Report. Instruments for Evaluating Undergraduate Medical Education in Complementary and Integrative Medicine: A Systematic Review. Australian Naturopaths Approach to the Clinical Management of Patients Presenting with Sleep Disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1